APRISO
mesalamine
- Strength
- 375 mg/1
- Form
- Capsule, Extended Release
- Class
- Aminosalicylate
Salix Pharmaceuticals, Inc.
Mesalamine
Listed by Sun Pharmaceutical Industries, Inc.
- Strength
- 1.2 g/1
- Form
- Tablet, Delayed Release
- Route
- Oral
- Class
- Aminosalicylate
What it contains
- Mesalamine 1.2 g/1
FDA record
| Dosage form | Tablet, Delayed Release |
|---|---|
| Route | Oral |
| Drug class | Aminosalicylate |
| Approval route | ANDA — approved generic |
| NDC code | 63304-175 |
| FDA application | ANDA211858 |
| RxNorm concept | 686429 |
| Package sizes listed | 1 |
| Marketed since | February 2019 |
Other products containing Mesalamine
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Canasa
Mesalamine
- Strength
- 1000 mg/1
- Form
- Suppository
- Class
- Aminosalicylate
Allergan, Inc.
Lialda
mesalamine
- Strength
- 1.2 g/1
- Form
- Tablet, Delayed Release
- Class
- Aminosalicylate
Takeda Pharmaceuticals America, Inc.
mesalamine
- Strength
- 375 mg/1
- Form
- Capsule, Extended Release
- Class
- Aminosalicylate
Teva Pharmaceuticals USA, Inc.
Mesalamine
- Strength
- 1.2 g/1
- Form
- Tablet, Delayed Release
- Class
- Aminosalicylate
American Health Packaging
Mesalamine
- Strength
- 4 g/60mL
- Form
- Enema
- Class
- Aminosalicylate
ANI Pharmaceuticals, Inc.
Mesalamine
- Strength
- 500 mg/1
- Form
- Capsule, Extended Release
- Class
- Aminosalicylate
Sun Pharmaceutical Industries Inc.
Mesalamine
- Strength
- .375 g/1
- Form
- Capsule, Extended Release
- Class
- Aminosalicylate
Zydus Pharmaceuticals USA Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.